These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 11771738)

  • 21. The proteasome: a macromolecular assembly designed for controlled proteolysis.
    Zwickl P; Voges D; Baumeister W
    Philos Trans R Soc Lond B Biol Sci; 1999 Sep; 354(1389):1501-11. PubMed ID: 10582236
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proteolysis, the ubiquitin-proteasome system, and renal diseases.
    Debigaré R; Price SR
    Am J Physiol Renal Physiol; 2003 Jul; 285(1):F1-8. PubMed ID: 12788783
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comprehensive mass spectrometric analysis of the 20S proteasome complex.
    Huang L; Burlingame AL
    Methods Enzymol; 2005; 405():187-236. PubMed ID: 16413316
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulatory subunit complex dissociated from 26S proteasome: isolation and characterization.
    Akaishi T; Yokosawa H; Sawada H
    Biochim Biophys Acta; 1995 Dec; 1245(3):331-8. PubMed ID: 8541309
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The ubiquitin-proteasome pathway: review of a novel intracellular mechanism of muscle protein breakdown during sepsis and other catabolic conditions.
    Hasselgren PO; Fischer JE
    Ann Surg; 1997 Mar; 225(3):307-16. PubMed ID: 9060588
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transferring substrates to the 26S proteasome.
    Hartmann-Petersen R; Seeger M; Gordon C
    Trends Biochem Sci; 2003 Jan; 28(1):26-31. PubMed ID: 12517449
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Age-dependent declines in proteasome activity in the heart.
    Bulteau AL; Szweda LI; Friguet B
    Arch Biochem Biophys; 2002 Jan; 397(2):298-304. PubMed ID: 11795886
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Degradation of oxidized proteins by the 20S proteasome.
    Davies KJ
    Biochimie; 2001; 83(3-4):301-10. PubMed ID: 11295490
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The relationship between skeletal muscle proteolysis and ubiquitin-proteasome proteolytic pathway in burned rats.
    Chai J; Wu Y; Sheng Z
    Burns; 2002 Sep; 28(6):527-33. PubMed ID: 12220909
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Apoptosis in Schwann cell cultures is closely interrelated with the activity of the ubiquitin-proteasome proteolytic pathway.
    Pasquini LA; Besio Moreno M; Lopez Salon M; Soto EF
    Neurochem Res; 2002 Nov; 27(11):1401-19. PubMed ID: 12512944
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure and functions of the 20S and 26S proteasomes.
    Coux O; Tanaka K; Goldberg AL
    Annu Rev Biochem; 1996; 65():801-47. PubMed ID: 8811196
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of ageing on proteasome structure and function in human lymphocytes.
    Carrard G; Dieu M; Raes M; Toussaint O; Friguet B
    Int J Biochem Cell Biol; 2003 May; 35(5):728-39. PubMed ID: 12672464
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alzheimer's disease associated presenilin 1 interacts with HC5 and ZETA, subunits of the catalytic 20S proteasome.
    Van Gassen G; De Jonghe C; Pype S; Van Criekinge W; Julliams A; Vanderhoeven I; Woodrow S; Beyaert R; Huylebroeck D; Van Broeckhoven C
    Neurobiol Dis; 1999 Oct; 6(5):376-91. PubMed ID: 10527805
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Degradation of an ubiquitin-conjugated protein is associated with myoblast differentiation in primary cell culture.
    Gardrat F; Montel V; Raymond J; Azanza JL
    Biochem Mol Biol Int; 1999 Mar; 47(3):387-96. PubMed ID: 10204075
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The 20S/26S proteasomal pathway of protein degradation in muscle tissue.
    Dahlmann B; Kuehn L
    Mol Biol Rep; 1995; 21(1):57-62. PubMed ID: 7565666
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative resistance of the 20S and 26S proteasome to oxidative stress.
    Reinheckel T; Sitte N; Ullrich O; Kuckelkorn U; Davies KJ; Grune T
    Biochem J; 1998 Nov; 335 ( Pt 3)(Pt 3):637-42. PubMed ID: 9794805
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interaction of the Doa4 deubiquitinating enzyme with the yeast 26S proteasome.
    Papa FR; Amerik AY; Hochstrasser M
    Mol Biol Cell; 1999 Mar; 10(3):741-56. PubMed ID: 10069815
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Manipulation of the ubiquitin-proteasome pathway in cachexia: pentoxifylline suppresses the activation of 20S and 26S proteasomes in muscles from tumor-bearing rats.
    Combaret L; Rallière C; Taillandier D; Tanaka K; Attaix D
    Mol Biol Rep; 1999 Apr; 26(1-2):95-101. PubMed ID: 10363654
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IGF-I has no effect on postexercise suppression of the ubiquitin-proteasome system in rat skeletal muscle.
    Kee AJ; Taylor AJ; Carlsson AR; Sevette A; Smith RC; Thompson MW
    J Appl Physiol (1985); 2002 Jun; 92(6):2277-84. PubMed ID: 12015337
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The components of the proteasome system and their role in MHC class I antigen processing.
    Krüger E; Kuckelkorn U; Sijts A; Kloetzel PM
    Rev Physiol Biochem Pharmacol; 2003; 148():81-104. PubMed ID: 12687403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.